Adjuvant Chemotherapy Use and Health Care Costs After Introduction of Genomic Testing in Breast Cancer
Loading...
Penn collection
Research Briefs
Degree type
Discipline
Subject
personalized medicine and genomics
medical decision making
Analytical, Diagnostic and Therapeutic Techniques and Equipment
Health Services Research
medical decision making
Analytical, Diagnostic and Therapeutic Techniques and Equipment
Health Services Research
Funder
Grant number
Copyright date
Distributor
Author
Wong, Yu-Ning
Mitra, Nandita
Vachani, Anil
Hin, Sakhena
Yang, Lin
Smith-McLallen, Aaron
Groeneveld, Peter W
Contributor
Abstract
Genomic testing in patients with early-stage breast cancer is associated with decreased use of chemotherapy and lower costs in younger patients, and slightly increased use of chemotherapy and higher costs in older patients. Genomic testing in actual practice may “rule out” chemotherapy in younger women, and “rule in” chemotherapy in older women.
Advisor
Date Range for Data Collection (Start Date)
Date Range for Data Collection (End Date)
Digital Object Identifier
Series name and number
Publication date
2016-02-03